Ceftaroline Fosamil

FDA Approved: * September 21, 2021
Pharm Company: * APOTEX
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ceftaroline Fosamil Overview

Ceftaroline fosamil (INN) /sftærolin/, brand name Teflaro in the US and Zinforo in Europe,[1][2] is a cephalosporin antibiotic with anti-MRSA activity.[3] Ceftaroline fosamil is a prodrug of ceftaroline. It is active against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria. It retains some activity of later-generation cephalosporins having broad-spectrum activity against Gram-negative bacteria, but its eff...

Read more Ceftaroline Fosamil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ceftaroline_fosamil

Recent Ceftaroline Fosamil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ceftaroline Fosamil
  • Injection: 600mg
  • Powder: 400mg/vial, 600mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ceftaroline Fosamil or a similar ingredient: (1 result)